Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
54149-17-6
31255-10-4
73342-17-3
2092628-73-2
54550-36-6
76779-16-3
587841-73-4 | ZCL 278 | AA00ECC8 | MFCD03623090
6311-73-5 | Methyl 5-nitro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate | AA00ECGX | MFCD01346736
62596-29-6 | Morusin | AA00ECMM | MFCD09953814
5632-81-5 | 3,5-Diamino-2-chloropyridine | AA00ECT4 | MFCD09757507
63845-33-0 | N-Cbz-4-piperidinepropionic acid | AA00ED1C | MFCD02179010
596845-30-6 | 2-Bromo-6-fluoro-4-(trifluoromethyl)quinoline | AA00ED81 | MFCD10574949
59587-44-9 | 2-ETHYLHEXYL PELARGONATE | AA00EDGW | MFCD00048954
65220-86-2 | 1-(trifluoroacetyl)piperidin-4-one | AA00EDPT | MFCD09971275
59194-21-7 | 5-METHYL-2-(1H-PYRROL-1-YL)ANILINE | AA00EDU3 | MFCD00047064
6340-03-0 | 2-(1H-Benzimidazol-1-yl)ethanol hydrochloride | AA00EDXS | MFCD00483391